Search Results

Filter
  • 1-7 of  7 results for ""Bone Morphogenetic Protein Receptors, Type II""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling.

  • Authors : Jin W; Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Yun C

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*metabolism ; Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/*metabolism ; Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/*metabolism

  • Source: Cancer research [Cancer Res] 2007 Oct 15; Vol. 67 (20), pp. 9869-77.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.

  • Authors : Deng L; Innovation Center for Cell Biology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui, China.; Shang L

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology ; MicroRNAs/MicroRNAs/MicroRNAs/*physiology ; Neoplastic Stem Cells/Neoplastic Stem Cells/Neoplastic Stem Cells/*physiology

  • Source: Cancer research [Cancer Res] 2014 Nov 15; Vol. 74 (22), pp. 6648-60. Date of Electronic Publication: 2014 Sep 12.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.

  • Authors : Herrera B; Growth Factor Signalling Laboratory, The Beatson Institute for Cancer Research, Glasgow, United Kingdom.; van Dinther M

Subjects: Activin Receptors, Type I/Activin Receptors, Type I/Activin Receptors, Type I/*metabolism ; Growth Differentiation Factors/Growth Differentiation Factors/Growth Differentiation Factors/*metabolism ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*metabolism

  • Source: Cancer research [Cancer Res] 2009 Dec 15; Vol. 69 (24), pp. 9254-62.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.

  • Authors : Yang S; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.; Pham LK

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*metabolism ; Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/*pharmacology ; Chemokine CXCL12/Chemokine CXCL12/Chemokine CXCL12/*metabolism

  • Source: Cancer research [Cancer Res] 2008 Jan 01; Vol. 68 (1), pp. 198-205.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.

  • Authors : Kim IY; Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland, USA. ; Lee DH

Subjects: Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/*metabolism ; Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/*pathology ; Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/*biosynthesis

  • Source: Cancer research [Cancer Res] 2004 Oct 15; Vol. 64 (20), pp. 7355-60.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

  • Authors : Pouliot F; Oncology and Molecular Endocrinology Research Center, Centre Hospitalier de l'Université Loval Research Center Centre Hospitalier Universitaire de Quebec and Laval University, Sainte-Foy, Quebec, G1V 4G2 Canada.; Blais A

Subjects: Transforming Growth Factor beta*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*metabolism ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology

  • Source: Cancer research [Cancer Res] 2003 Jan 15; Vol. 63 (2), pp. 277-81.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
Academic Journal

Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.

  • Authors : Kim IY; Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA.; Lee DH

Subjects: Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*metabolism ; Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/*biosynthesis ; Receptors, Growth Factor/Receptors, Growth Factor/Receptors, Growth Factor/*biosynthesis

  • Source: Cancer research [Cancer Res] 2000 Jun 01; Vol. 60 (11), pp. 2840-4.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

×
  • 1-7 of  7 results for ""Bone Morphogenetic Protein Receptors, Type II""